Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension  Pulmonology Advisor

Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.



Comments

Post a Comment

Popular posts from this blog

4 Symptoms of Stress You Should Never Ignore - AARP

Image
Vadym Pastukh/Getty Images Wins and medals aren't the only things grabbing attention at this year's Olympic games in Tokyo: Mental health awareness is also in the spotlight, after U.S. star gymnast Simone Biles' decision to withdraw from some events in order to focus on her emotional well-being.  Olympians or not, we're all susceptible to stress, whether from job or family pressures or obligations like caregiving. Here are the physical and mental signs that experts say could signal trouble.   1. Insomnia and difficulty sleeping  Can't fall or stay asleep? Insomnia is a class...
Read more

What is lung scraping for COPD, and who may need it? - Medical News Today

Image
Lung scraping, or thoracentesis, involves the removal of fluid or air from the space between the chest wall and the lungs. In some cases, doctors may perform the procedure on people who have chronic obstructive pulmonary disease (COPD). It is not a standard treatment for COPD, but it may be necessary if a person has pleural effusion or empyema. This article looks at COPD and lung scraping in more detail. It explains who may need the procedure and discusses the risks, preparation, and aftercare. It also outlines other procedures for COPD. Lung scraping involves removing air or excess fluid from the pleural space. The pleural space is the area between the lungs and the chest wall. The medical term for lung scraping is thoracentesis. Doctors perform the procedure for therapeutic reasons or diagnostic purposes. Therapeutic thoracentesis helps decrease the shortness of breath and pain that result from the pressure of the fluid on the lungs. It typically involves the removal of a large volu...
Read more

Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio

Image
Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio Posted: 02 Aug 2019 06:01 AM PDT Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in July. See below for links to a study on reducing antibiotic use for COPD exacerbations, the outcome of an FDA advisory committee meeting on nintedanib for a rare form of interstitial lung disease, updates on treatment of respiratory infections in patients with cystic fibrosis and more. C-reactive protein testing safely reduces antibiotic use for COPD exacerbations The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a...
Read more